| 46.12 Data as of Jun 19 |  -0.3262 / -0.70%Today’s Change | 42.50 Today|||52-Week Range 55.68 | +3.57% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $36.7B |
Company Description
Takeda Pharmaceutical Co., Ltd. is a research-based global pharmaceutical company engaged in the manufacture, import, export, and marketing of pharmaceutical drugs. Its operations are carried out through the following segments: Ethical Drugs Business, Consumer Healthcare Business, and Other Business. Ethical Drugs Business segment provides the manufacture and sale of pharmaceutical products. The Consumer Healthcare Business segment provides the manufacture and sale of healthcare drugs and quasi-drugs. The Other Business segment provides the manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded on June 12, 1781 and is headquartered in Osaka, Japan.
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Yasuchika Hasegawa | President, CEO & Representative Director |
| Hiroshi Takahara | Manager-Business Management & IR Contact |
| Satoshi Adachi | Senior Director-Production Technology & Research |
| Tadataka Yamada, MD | Director, Chief Medical & Scientific Officer |
| Haruhiko Hirate | Senior Vice President |
.
